Patents for C07C 335 - Thioureas, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (3,175) |
---|
03/22/2012 | CA2811294A1 Stabilization of ozone-labile fluorescent dyes by thiourea |
03/08/2012 | DE102010037277A1 New urea derivative useful for controlling plant pathogenic germs and for preventing disease infestation on plants |
02/23/2012 | WO2012021991A1 Anti-viral carbamimidothioic acid esters |
02/23/2012 | CA2845241A1 Anti-viral carbamimidothioic acid esters |
02/08/2012 | EP2415756A1 Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity |
01/26/2012 | WO2012010644A1 Process for the synthesis of isothiocyanates and derivatives thereof and uses of same |
01/26/2012 | WO2011152471A3 Rechargeable battery, functional polymer, and method for synthesis thereof |
01/24/2012 | US8101640 Antibacterial agents |
01/24/2012 | CA2439838C (2-hydroxy)ethyl-thioureas useful as modulators of alpha2b adrenergic receptors |
01/19/2012 | US20120015961 Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity |
01/12/2012 | WO2012004549A1 Phenoxypropanol derivatives and their use in treating cardiac and cardiovascular diseases |
01/04/2012 | CN102304104A TRPV1 (transient receptor potential cation channel, subfamily V, member 1) antagonists, and preparation method and medical application thereof |
12/27/2011 | US8084641 Organocataslysts and methods of use in chemical synthesis |
12/27/2011 | US8084615 Antibacterial agents |
12/22/2011 | WO2011159137A2 Novel thiourea or urea derivative, preparation method thereof, and pharmaceutical composition for preventing or treating aids, containing same as active ingredient |
12/21/2011 | CN101531622B 1-苯甲酰基-3-取代苯基硫脲的微波合成法 1-benzoyl-3-substituted phenyl thiourea microwave synthesis |
12/08/2011 | WO2011152471A2 Rechargeable battery, functional polymer, and method for synthesis thereof |
12/07/2011 | CN102267924A 抗菌剂 Antibacterial agents |
12/06/2011 | US8071650 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
12/01/2011 | US20110294878 Inhibitors of Dimethylarginine Dimethylaminohydrolase |
11/23/2011 | EP1458831B1 Composition containing a polymerizable reducing agent, kit, and method |
11/23/2011 | CN101003502B Compound of amide chlorotrifluoro chrysanthemic acid containing thiourea, preparation and application |
11/17/2011 | WO2011140832A1 Hexaketide compound and medicinal use thereof |
11/17/2011 | WO2011140681A1 Acrylamide compounds and use thereof for inhibiting apoptosis |
11/16/2011 | EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
11/16/2011 | CN102241673A Acrylamide compounds and medicinal uses thereof |
11/10/2011 | WO2011076784A3 New inhibitors of cyclophilins and uses thereof |
11/10/2011 | US20110275663 N-Acylthiourea and N-Acylurea Inhibitors of the Hedgehog Protein Signalling Pathway |
11/01/2011 | US8048867 9-substituted minocycline compounds |
10/13/2011 | US20110251216 Compositions and methods for inhibiting ezh2 |
10/12/2011 | EP1909783B1 Illudin analogs useful as anticancer agents |
09/27/2011 | US8026239 Cell differentiation inducer |
09/15/2011 | US20110223093 Ionic liquid systems for carbon dioxide and sulfur dioxide removal |
09/09/2011 | WO2011108724A1 Prophylactic or therapeutic agent for diabetes or obesity |
09/09/2011 | WO2011108690A1 Alkylamine derivative |
09/09/2011 | CA2791174A1 Alkylamine derivative |
09/07/2011 | EP2362866A1 Isoprenyl compounds and methods thereof |
08/31/2011 | CN102167675A Methods for preparing N-alkoxycarbonyl isothiocyanate and derivative thereof |
08/31/2011 | CN102166434A Mesoporous material coating based open-tubular capillary chromatographic column and preparation method thereof |
08/24/2011 | EP1931622B1 Phenyloxy substituted phenylamidine derivatives as pesticides |
08/17/2011 | CN102153498A Resveratrol analogue and preparation method and application thereof |
08/10/2011 | EP1436256B1 Preparation process of some halogeno-substituted monosulfides and their hydroxy-monosulfide or isothiouronium bromide equivalents as intermediates |
08/10/2011 | CN102146049A Method for synthesizing thiourea nitrate and use thereof as solid nitration reagent |
08/09/2011 | CA2431083C Inflammatory cytokine release inhibitor |
08/04/2011 | CA2787784A1 Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders |
08/03/2011 | EP1989174B1 Substituted cyclohexylmethyl derivatives |
08/02/2011 | US7989660 Bactericide against gramnegative bacteria; respiaratory system disorders |
07/26/2011 | CA2367787C Ligands for metabotropic glutamate receptors |
07/21/2011 | US20110178212 Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group |
07/19/2011 | US7982045 2′-substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
07/14/2011 | WO2011084106A1 Novel amphiphiles |
07/14/2011 | US20110172174 Antibacterial agents |
07/06/2011 | CN1777577B Antibacterial agents |
07/05/2011 | CA2400185C Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
06/30/2011 | CA2784600A1 New inhibitors of cyclophilins and uses thereof |
06/22/2011 | EP2102147B1 Chiral cyclic beta-amino acids and their derivates, pharmaceutical compositions containing them and the use of such compounds |
06/21/2011 | US7964642 Antiinflammatory agents, analgesics; 2-halo-4-hydroxy-5-methoxyphenyl-functional urea or thiourea compounds such as 1-(p-trifluoromethylbenzyl)-3-(2-iodo-4-hydroxy-5-methoxybenzyl)thiourea |
06/16/2011 | WO2011071078A1 Aromatic compound, modification carrier that uses same and is used for synthesizing an oligonucleotide derivative, oligonucleotide derivative, and oligonucleotide construct |
06/16/2011 | WO2011022489A3 (bis) urea and (bis) thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders |
06/15/2011 | CN102093274A Chalcone-containing acylthiourea compounds and preparation method and use thereof |
06/03/2011 | WO2011031764A3 Compounds and related methods of use |
06/01/2011 | CN101372750B Novel method for preparing thiourea dioxide |
05/31/2011 | CA2319080C Multivalent antibacterial agents |
05/25/2011 | CN102070500A Preparation method of thiophanate methyl raw pesticide |
05/19/2011 | US20110118116 Azolin-2-ylamino Compounds for Combating Animal Pests |
05/18/2011 | EP2322501A1 4-dedimethylamino tetracycline compounds |
05/11/2011 | CN101307016B Method for synthesizing 2,6-diisopropyl-4-phenoxy phenylthiourea |
05/11/2011 | CN101225065B Chiral compound having multi-hydrogen bonds dual-function as well as synthetic method and use thereof |
05/04/2011 | CN102040547A Salicyl thiourea derivative, preparation method and application |
04/27/2011 | EP2313381A1 Azolin-2-ylamino compounds for combating animal pests |
04/27/2011 | CN102030685A Anti-beta-farnesene analog containing guanidine or nitro-ethylene as well as preparation method and applications thereof |
04/21/2011 | US20110092467 7-And 9-Carbamate, Urea, Thiourea, Thiocarbamate, And Heteroaryl-Amino Substituted Tetracycline Compounds |
04/20/2011 | EP2311799A1 4-dedimethylamino tetracycline compounds |
04/20/2011 | EP2311798A1 4-dedimethylamino tetracycline compounds |
04/20/2011 | EP2311797A1 4-dedimethylamino tetracycline compounds |
04/20/2011 | EP2311796A1 4-dedimethylamino tetracycline compounds |
04/14/2011 | US20110086409 Surfactant-Based Monolithic Columns, Methods for Making the Same, and Method for Using the Same |
04/13/2011 | EP2308832A1 9-Substituted minocycline compounds |
04/06/2011 | EP2305636A1 Selective androgen receptor modulators and methods of use thereof |
03/30/2011 | CN101993401A Preparation method of 1-isopropyl-3-tertiary butyl thiocarbamide |
03/29/2011 | US7915293 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases |
03/17/2011 | US20110065760 Compounds for the inhibition of rotamases and use thereof |
03/16/2011 | EP2295402A2 Antibacterial agents |
03/15/2011 | CA2458266C Substituted urea retinoid agonists ii |
03/15/2011 | CA2343009C Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers |
03/09/2011 | EP2291352A2 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway |
03/08/2011 | CA2471877C Composition containing a polymerizable reducing agent, kit and method |
03/02/2011 | CN101982460A Dehydroabieticacyl thiourea derivatives, preparation method thereof and application |
02/24/2011 | WO2011022489A2 (bis) urea and (bis) thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders |
02/09/2011 | EP2280933A1 2 -aminotetralin derivatives as mu opioid receptor antagonists |
02/02/2011 | CN101337206B Sulphide ore floation collector and use method of diacyl bis-thiourea and preparation method thereof |
02/01/2011 | US7879492 redox system; lithium batteries; nontoxic; improved electroconductivity |
01/27/2011 | WO2010142956A3 Aroylthiourea and arylthiocarbonylurea derivatives |
01/27/2011 | US20110021529 P53 activating compounds |
01/26/2011 | EP1480941B1 Urea derivatives as hiv aspartyl protease inhibitors |
01/19/2011 | CN101108820B Isothiuronium salt and method of manufacturing the same and method for manufacturing substituted benzene ethyl mercaptan compounds |
01/13/2011 | WO2011003191A1 Compositions and methods for enhancing virus efficacy |
01/13/2011 | WO2010135170A3 Nitrile derivatives and their pharmaceutical use and compositions |
01/13/2011 | CA2765066A1 Compositions and methods for enhancing virus efficacy |
01/04/2011 | US7863332 peroxisome proliferator activated receptor agonists, such as (E)-3-[3'-(3-heptyl-1-methylureido)biphenyl-4-yl]acrylic acid, useful in human or veterinary medicine (in dermatology, cardiovascular diseases, immune diseases and/or metabolism of lipids); cosmetics |